Cutting Edge: The Nucleotide Receptor P2X7Contains Multiple Protein- and Lipid-Interaction Motifs Including a Potential Binding Site for Bacterial Lipopolysaccharide-Reference-Cited by-同舟云学术

Cutting Edge: The Nucleotide Receptor P2X7Contains Multiple Protein- and Lipid-Interaction Motifs Including a Potential Binding Site for Bacterial Lipopolysaccharide

Published:2001-08-15 Issue:4 Volume:167 Page:1871-1876
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Denlinger Loren C.,Fisette Philip L.,Sommer Julie A.,Watters Jyoti J.,Prabhu Usha,Dubyak George R.,Proctor Richard A.,Bertics Paul J.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Bacterial lipopolysaccharide-stimulated GTPase activity in RAW 264.7 macrophage membranes

2. Protection of mice from endotoxic death by 2-methylthio-ATP.

3. Extracellular ATP Enhances mRNA Levels of Nitric Oxide Synthase and TNF-α in Lipopolysaccharide-Treated Raw 264.7 Murine Macrophages

4. Regulation of Inducible Nitric Oxide Synthase Expression by Macrophage Purinoreceptors and Calcium

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders;Frontiers in Pharmacology;2024-07-30

2. Loss-of-function/gain-of-function polymorphisms of the ATP sensitive P2X7R influence sepsis, septic shock, pneumonia, and survival outcomes;Frontiers in Immunology;2024-06-20

3. The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression;Biochemical and Biophysical Research Communications;2024-05

4. Extracellular ATP contributes to the reactive oxygen species burst and exaggerated mitochondrial damage in D-galactosamine and lipopolysaccharide-induced fulminant hepatitis;International Immunopharmacology;2024-03

5. Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases;Frontiers in Immunology;2024-02-02